258 related articles for article (PubMed ID: 33119725)
1. "Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes.
Singh S; Maurya RP; Singh RK
PLoS Pathog; 2020 Oct; 16(10):e1008969. PubMed ID: 33119725
[TBL] [Abstract][Full Text] [Related]
2. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
3. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
Front Immunol; 2020; 11():2059. PubMed ID: 33013871
[TBL] [Abstract][Full Text] [Related]
4. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
Front Immunol; 2020; 11():970. PubMed ID: 32574258
[TBL] [Abstract][Full Text] [Related]
5. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
6. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
7. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
8. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
[TBL] [Abstract][Full Text] [Related]
9. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
10. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
11. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel M; Gursel I
Allergy; 2020 Jul; 75(7):1815-1819. PubMed ID: 32339299
[No Abstract] [Full Text] [Related]
12. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
13. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
14. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data.
Wassenaar TM; Buzard GS; Newman DJ
Lett Appl Microbiol; 2020 Nov; 71(5):498-505. PubMed ID: 32734625
[TBL] [Abstract][Full Text] [Related]
15. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
O'Connor E; Teh J; Kamat AM; Lawrentschuk N
Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
[No Abstract] [Full Text] [Related]
16. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
17. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
Gupta PK
Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
[TBL] [Abstract][Full Text] [Related]
18. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
Escobar LE; Molina-Cruz A; Barillas-Mury C
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17720-17726. PubMed ID: 32647056
[TBL] [Abstract][Full Text] [Related]
19. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
[TBL] [Abstract][Full Text] [Related]
20. Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir C; Kucuksezer UC; Tamay ZU
Allergy; 2020 Jul; 75(7):1824-1827. PubMed ID: 32330314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
